MedPath

Changes in the Tear Film With Scleral Contact Lens Wear for Keratoconic Eyes

Not Applicable
Completed
Conditions
Keratoconus
Interventions
Device: ZenLens
Registration Number
NCT02806921
Lead Sponsor
University of Waterloo
Brief Summary

The purpose of this study is to investigate changes in the level of inflammatory mediators in the tear film of scleral contact lens wearers in a keratoconic population.

Detailed Description

Scleral contact lenses are rigid gas permeable lenses designed to rest on the sclera while vaulting over the cornea with a fluid reservoir. The use of scleral contact lenses has become the current standard of practice as a nonsurgical management of corneal ectasia and ocular surface diseases. Cases have been recently presented of scleral lens wearers exhibiting adverse corneal findings and conjunctival injection from lens wear. These findings are likely associated with the mechanical and hypoxic effects due to poor fitting characteristics at the limbal area. Tear film analysis detecting changes in the levels of proteinases and cytokines have helped researchers gain a better understanding of the pathophysiology of complications in soft contact lenses wearers, dry eye, and keratoconus. Ultimately, this study will provide insights in relating scleral lens fitting characteristics and corneal and limbal physiological responses.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
13
Inclusion Criteria
  • Had been diagnosed with keratoconus in at least one eye.
  • Is at least 18 years of age and has full legal capacity to volunteer.
  • Has read and understood the information consent letter.
  • Is willing and able to follow instructions and maintain the appointment schedule.
Exclusion Criteria
  • Is using any topical medications that will affect ocular health.
  • Has any ocular pathology or severe insufficiency of lacrimal secretion (severe dry eyes) that would affect the wearing of contact lenses.
  • Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye.
  • Has any clinically significant lid or conjunctival abnormalities and active neovascularization.
  • Is aphakic.
  • Has undergone any corneal surgery.
  • Is participating in any other type of eye related clinical or research study.
  • Has any known allergies or sensitivity to the diagnostic pharmaceuticals or products, such as fluorescein, used in this study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
ZenLens with Low limbal clearanceZenLensScleral contact lens designed to provide approximately 25 microns of limbal clearance.
ZenLens with High limbal clearanceZenLensScleral contact lens designed to provide approximately 80 microns of limbal clearance.
Primary Outcome Measures
NameTimeMethod
Tear Protein2 weeks of lens wear with daily schedule of 6-8 hours.

To measure the level proteases and cytokines in each of the samples using Meso Scale Discovery system (MSD-ECL).

Secondary Outcome Measures
NameTimeMethod
Comfort2 weeks of lens wear with daily schedule of 6-8 hours.

Participants will be asked to rate their ocular comfort, dryness, burning and vision with the contact lenses.

Corneal thickness2 weeks of lens wear with daily schedule of 6-8 hours.

Their corneal thickness will be measured with the Visante OCT.

Bulbar and limbal hyperemia2 weeks of lens wear with daily schedule of 6-8 hours.

The eyes of the participants will be imaged using the Keratograph® 5.

© Copyright 2025. All Rights Reserved by MedPath